VentiRx Pharmaceuticals, Inc. Appoints Kent Snyder to Board of Directors

Published: Apr 16, 2007

SAN DIEGO, April 16 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel medicines for the treatment of cancer and infectious, respiratory and autoimmune diseases, announced today the appointment of Kent Snyder to its Board of Directors.

Back to news